Bigul

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

In furtherance to our intimation dated 06.11. 2020, this is to inform you that pursuant to the provisions of Sec 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Company is in the process of conducting postal ballot (only by means of remote e-voting) for seeking approval of members of the Company for business as specified in the Postal Ballot Notice dated 06.11.2020. In terms of Reg 30 of SEBI (LODR) Reg, 2015, please find enclosed the Postal Ballot Notice dated 06.11.2020 The remote e-voting period commences on Saturday, 28.11.2020 at 9.00 am and shall remain open for a period of 30 days i.e. till Sunday, 27.12. 2020 at 5.00 pm. CS Manish L. Ghia, Partner, M/s Manish Ghia & Associates, Company Secretaries, Mumbai has been appointed as Scrutinizer for conducting Postal Ballot process in fair and transparent manner. Kindly take note of the same.
27-11-2020

Buy Alkem Laboraties; target of Rs 3570: Motilal Oswal

Motilal Oswal is bullish on Alkem Laboraties recommended buy rating on the stock with a target price of Rs 3570 in its research report dated November 07, 2020.
10-11-2020

Buy Alkem Laboratories; target of Rs 3290: Dolat Capital Market

Dolat Capital Market is bullish on Alkem Laboratories has recommended buy rating on the stock with a target price of Rs 3290 in its research report dated November 07, 2020.
07-11-2020

Earnings Call for Q2FY21 of Alkem Laboratories Ltd.

Conference Call with Alkem Laboratories Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
06-11-2020

Alkem Laboratories Q2 net profit up 27% to Rs 482 crore

The company had posted a net profit of Rs 380.52 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a BSE filing.
06-11-2020
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

We refer to our earlier communication dated 28th September, 2020 regarding closure of trading window (for the purpose of financial results for the quarter and half year ended 30th September, 2020) starting from 29th September, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half year ended 30th September, 2020 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and half year ended 30th September, 2020 having been communicated to the Stock Exchanges, today i.e. 06th November, 2020, the trading window shall open on 09th November, 2020.
06-11-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR)- Cut-Off Date For Postal Ballot

This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Board of Directors at its meeting held today i.e. 06th November, 2020 has decided to seek approval of the shareholders by way of postal ballot (including voting by electronic means) for increase in remuneration of Mr. Sandeep Singh (DIN: 01277984), Managing Director of the Company. The Company has fixed 20th November, 2020 as cut-off date for ascertaining the eligibility of shareholders for dispatch of Postal Ballot Notice and voting through electronic means/physical Postal Ballot Form. Kindly take note of the same.
06-11-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY21 and H1FY21 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same.
06-11-2020
Bigul

Alkem Laboratories Ltd - 539523 - Subject Results- Financial Results For Quarter And Half Year Ended September 30, 2020

In continuation of our letter dated 28th October, 2020 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') the Board of Directors of the Company, at its meeting held today, i.e. 06th November, 2020, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2020. Accordingly we are enclosing herewith the Standalone and Consolidated Unaudited Financial Results for the quarter and half ended 30th September, 2020 and the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.00 am and concluded at 1.30 pm.
06-11-2020
Bigul

Alkem Laboratories Ltd - 539523 - Outcome Of Board Meeting Dated 06/11/2020

The Board of Directors at its meeting held today i.e. 06th November, 2020, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2020. Accordingly, we are enclosing herewith Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2020 and the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.30 p.m.
06-11-2020
Next Page
Close

Let's Open Free Demat Account